Economic Costs of Rotavirus Gastroenteritis and Cost‐Effectiveness of Vaccination in Developing Countries
The Journal of Infectious Diseases2009Vol. 200(s1), pp. S16–S27
Citations Over TimeTop 10% of 2009 papers
Richard Rheingans, Lynn Antil, Robert Dreibelbis, Laura Jean Podewils, Joseph Bresee, Umesh D. Parashar
Abstract
Vaccination is a cost-effective strategy to reduce the health and economic burden of rotavirus. The cost-effectiveness of vaccination depends mostly on vaccine price and reaching children at highest risk of mortality.
Related Papers
- → The economic impact of obesity in the United States(2010)406 cited
- → The economic impact of obesity in the United States(2010)347 cited
- → Economic Evaluation Approaches in the Field of Disaster Health Management(2023)4 cited
- FRAMEWORK FOR CLASSIFYING AND EVALUATING ECONOMIC IMPACTS CAUSED BY A TRANSPORTATION IMPROVEMENT(1990)
- → Economic Evaluations in the Canadian Mental Health System I: Theory behind Economic Evaluation*(1989)1 cited